The association of chronic kidney disease and metabolic syndrome with incident cardiovascular events: Multiethnic study of atherosclerosis

Cardiology Research and Practice

Volumn 1, Issue 1, 2012, Pages

  Agarwal, Subhashish ^a   Shlipak, Michael G ^b   Kramer, Holly ^c   Jain, Aditya ^d   Herrington, David M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN C; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUCASIAN; CHINESE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; GLOMERULUS FILTRATION RATE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT;

EID: 80053479137     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.1155/2012/806102     Document Type: Article

References (33)

1. Coresh J., Byrd-Holt D., Astor B. C., Briggs J. P., Eggers P. W., Lacher D. A., Hostetter T. H., Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000 Journal of the American Society of Nephrology 2005 16 1 180 188 (Pubitemid 43073171)
2. Chen J., Muntner P., Hamm L. L., Jones D. W., Batuman V., Fonseca V., Whelton P. K., He J., The metabolic syndrome and chronic kidney disease in U.S. adults Annals of Internal Medicine 2004 140 3 167 I39
3. Kurella M., Lo J. C., Chertow G. M., Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults Journal of the American Society of Nephrology 2005 16 7 2134 2140 (Pubitemid 41716445)
4. Alexander M. P., Patel T. V., Farag Y. M. K., Florez A., Rennke H. G., Singh A. K., Kidney pathological changes in metabolic syndrome: a cross-sectional study American Journal of Kidney Diseases 2009 53 5 751 759
5. Cleeman J. I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) Journal of the American Medical Association 2001 285 19 2486 2497 (Pubitemid 32433843)
6. Ford E. S., Giles W. H., Dietz W. H., Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey Journal of the American Medical Association 2002 287 3 356 359 (Pubitemid 34251969)
7. Ix J. H., Shlipak M. G., Chertow G. M., Whooley M. A., Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study Circulation 2007 115 2 173 179 (Pubitemid 46105715)
8. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C. Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization The New England Journal of Medicine 2004 351 13 1296 1370
9. Koenig W., Twardella D., Brenner H., Rothenbacher D., Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate Clinical Chemistry 2005 51 2 321 327 (Pubitemid 40175801)
10. Lakka H. M., Laaksonen D. E., Lakka T. A., Niskanen L. K., Kumpusalo E., Tuomilehto J., Salonen J. T., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men Journal of the American Medical Association 2002 288 21 2709 2716 (Pubitemid 35403784)
11. Gami A. S., Witt B. J., Howard D. E., Erwin P. J., Gami L. A., Somers V. K., Montori V. M., Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies Journal of the American College of Cardiology 2007 49 4 403 414 (Pubitemid 46135879)
12. Shlipak M. G., Fried L. F., Cushman M., Manolio T. A., Peterson D., Stehman-Breen C., Bleyer A., Newman A., Siscovick D., Psaty B., Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors Journal of the American Medical Association 2005 293 14 1737 1745
13. Foley R. N., Wang C., Collins A. J., Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES III study Mayo Clinic Proceedings 2005 80 10 1270 1277 (Pubitemid 41395958)
14. Chiu K. C., Chu A., Go V. L. W., Saad M. F., Hypovitaminosis D is associated with insulin resistance and cell dysfunction American Journal of Clinical Nutrition 2004 79 5 820 825 (Pubitemid 41103882)
15. Williams S., Malatesta K., Norris K., Vitamin D and chronic kidney disease Ethnicity amp; disease 2009 19 4 S5 8
16. Leung P. S., Chappell M. C., A local pancreatic renin-angiotensin system: endocrine and exocrine roles International Journal of Biochemistry and Cell Biology 2003 35 6 838 846 (Pubitemid 36379325)
17. Lau T., Carlsson P. O., Leung P. S., Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets Diabetologia 2004 47 2 240 248 (Pubitemid 38315360)
18. Bkenkamp A., Domanetzki M., Zinck R., Schumann G., Byrd D., Brodehl J., Cystatin Ca new marker of glomerular filtration rate in children independent of age and height Pediatrics 1998 101 5 875 881 (Pubitemid 28204840)
19. Newman D. J., Thakkar H., Edwards R. G., Wilkie M., White T., Grubb A. O., Price C. P., Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine Kidney International 1995 47 1 312 318
20. Shlipak M. G., Sarnak M. J., Katz R., Fried L. F., Seliger S. L., Newman A. B., Siscovick D. S., Stehman-Breen C., Cystatin C and the risk of death and cardiovascular events among elderly persons The New England Journal of Medicine 2005 352 20 2049 2060 (Pubitemid 40664306)
21. Shlipak M. G., Sarnak M. J., Katz R., Fried L., Seliger S., Newman A., Siscovick D., Stehman-Breen C., Cystatin-C and mortality in elderly persons with heart failure Journal of the American College of Cardiology 2005 45 2 268 271 (Pubitemid 40094736)
22. Stevens L. A., Coresh J., Schmid C. H., Feldman H. I., Froissart M., Kusek J., Rossert J., van Lente F., Bruce R. D., Zhang Y., Greene T., Levey A. S., Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD American Journal of Kidney Diseases 2008 51 3 395 406 (Pubitemid 351273480)
23. Bild D. E., Bluemke D. A., Burke G. L., Detrano R., Diez Roux A. V., Folsom A. R., Greenland P., Jacobs D. R., Kronmal R., Liu K., Nelson J. C., O'Leary D., Saad M. F., Shea S., Szklo M., Tracy R. P., Multi-ethnic study of atherosclerosis: objectives and design American Journal of Epidemiology 2002 156 9 871 881 (Pubitemid 35215769)
24. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L. Jr., Jones D. W., Materson B. J., Oparil S., Wright J. T. Jr., Roccella E. J., Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 2003 42 6 1206 1252 (Pubitemid 37553153)
25. Friedewald W. T., Levy R. I., Fredrickson D. S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clinical Chemistry 1972 18 6 499 502
26. Erlandsen E. J., Randers E., Kristensen J. H., Evaluation of the dade behring N latex cystatin C assay on the dade behring nephelometer II system Scandinavian Journal of Clinical and Laboratory Investigation 1999 59 1 1 8 (Pubitemid 29133539)
27. Grundy S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A., Gordon D. J., Krauss R. M., Savage P. J., Smith S. C., Spertus J. A., Costa F., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 2005 112 17 2735 2752 (Pubitemid 41532612)
28. Li R., Chambless L., Test for additive interaction in proportional hazards models Annals of Epidemiology 2007 17 3 227 236
29. Deo R., Wassel Fyr C. L., Fried L. F., Newman A. B., Harris T. B., Angleman S., Green C., Kritchevsky S. B., Chertow G. M., Cummings S. R., Shlipak M. G., Kidney dysfunction and fatal cardiovascular disease-an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study American Heart Journal 2008 155 1 62 68 (Pubitemid 350234767)
30. Iwashima Y., Horio T., Kamide K., Tokudome T., Yoshihara F., Nakamura S., Ogihara T., Rakugi H., Kawano Y., Additive interaction of metabolic syndrome and chronic kidney disease on cardiac hypertrophy, and risk of cardiovascular disease in hypertension American Journal of Hypertension 2010 23 3 290 298
31. Martins D., Ani C., Pan D., Ogunyemi O., Norris K., Renal dysfunction, metabolic syndrome and cardiovascular disease mortality Journal of Nutrition and Metabolism 2010 2010 8
32. Risch L., Herklotz R., Blumberg A., Huber A. R., Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients Clinical Chemistry 2001 47 11 2055 2059 (Pubitemid 33010731)
33. Wiesli P., Schwegler B., Spinas G. A., Schmid C., Serum cystatin C is sensitive to small changes in thyroid function Clinica Chimica Acta 2003 338 1-2 87 90 (Pubitemid 37456694)